Promising markers for the risk and prognosis of gestational diabetes mellitus

Abstract

The review provides information on the molecular genetic mechanisms for the development gestational diabetes mellitus (GDM). It gives data on the genetic identity of GDM and type 2 diabetes mellitus and considers a role of some adipokines and incretin hormones in the development of GDM. There is evidence for the role of magnesium and vitamin D deficiencies in the pathogenesis of gestational carbohydrate metabolic disturbances.

References

  1. Дедов И.И., Краснопольский В.И., Сухих Г.Т. Российский национальный консенсус «Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение». Сахарный диабет. 2012;4:4-10. doi: 10.14341/2072-0351-5531.
  2. Бондарь И.А., Малышева А.С. Изменения гемостаза у беременных с нарушениями углеводного обмена. Сахарный диабет. 2013;2:77-81. doi: 10.14341/2072-0351-3760.
  3. Саприна Т.В., Тимохина Е.С., Ворожцова И.Н. Проблема диагностики гестационного сахарного диабета по уровню гликированного гемоглобина. Сахарный диабет. 2012;4:63-68. doi: 10.14341/2072-0351-5540.
  4. Abell SK, De Courten B, Boyle JA, Teede HJ. Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus. Int J Mol Sci. 2015;16(6):13442-13473. doi: 10.3390/ijms160613442.
  5. Аметов А.С. Вклад современных исследований в понимание природы сахарного диабета 2-го типа и перспективы лечения. Терапевтический архив. 2014;1:4-9.
  6. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE. Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774-4779. doi: 10.1210/jc.2008-0772.
  7. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773-1779. doi: 10.1016/s0140-6736(09)60731-5.
  8. Alves L, Dutra S, Godoy Garcia Costa P, Ribeiro Velasco LF. Allele-Specifi c PCR Assay to Genotype SNP rs7903146 in TCF7L2 Gene for Rapid Screening of Diabetes Susceptibility. Arquivos Brasileiros de Endocrinologia & Metabologia. 2008;52(8):1362-1366. doi: 10.1590/s0004-27302008000800026.
  9. Liu Z, Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic betacell proliferation. J Biol Chem. 2008;283(13):8723-8735. doi: 10.1074/jbc.m706105200.
  10. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genet. 2006;38(3):320-323. doi: 10.1038/ng1732.
  11. Tong Y, Lin Y, Zhang Y, Yang J, Liu H, Zhang B. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet. 2009;10(15):1-25. doi: 10.1186/1471-2350-10-15.
  12. Luo YY, Wang HY, Han XY, Ren Q, Wang F, Zhang XY, Sun XQ, Zhou XH, Ji LN. Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population. Diab Res Clin Pract. 2009;85(2):139-146. doi: 10.1016/j.diabres.2009.04.024 .
  13. Peng S, Zhu Y, Lu B, Xu F, Li X, Lai M. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121 174 subjects. Mutagenesis. 2012;28(1):25-37. doi: 10.1093/mutage/ges048.
  14. Kang S, Xie Z, Zhang D. Association of the rs7903146 polymorphism in transcription factor 7-like 2 (TCF7L2) gene with gestational diabetes mellitus: a meta-analysis. Gynecol Endocrinol. 2013;29(10):873-877. doi: 10.3109/09513590.2013.813469.
  15. Torekov SS, Ma L, Grarup N, Hartmann B, Hainerova IA, Kielgast U, Kissow H, Rosenkilde M, GIANT Consortium, Leb J, Witte DR, Jorgensen T, Sandbaek A, Lauritzen T, Madsen OD, Wang J, Linneberg A, Madsbad S, Holst JJ, Hansen T, Pedersen O. Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterized by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1. Diabetologia. 2011;54(11):2820-2831. doi: 10.1007/s00125-011-2265-7.
  16. Huopio H, Cederberg H. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol. 2013;169(3):291-297. doi: 10.1530/eje-13-0286.
  17. Miehle K, Holger S, Fasshauer M. Leptin, Adiponectin and other Adipokines in Gestational Diabetes Mellitus and Pre-eclampsia. Clin Endocrinol. 2012;76(1):2-11. doi: 10.1111/j.1365-2265.2011.04234.x.
  18. Петунина Н.А., Кузина И.А. Роль гормонов жировой ткани в развитии осложнений беременности у женщин с ожирением. Ожирение и метаболизм. 2013;1:3-8. doi: 10.14341/2071-8713-5063.
  19. Catalano PM. Trying to understand gestational diabetes. Diabetic Med. 2014;31(3):273-281. doi: 10.1111/dme.12381.
  20. Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X. Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis. PLoS ONE. 2014;9(1):е87863. doi: 10.1371/journal.pone.0087863.
  21. Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol. 2004;103(3):519-525. doi: 10.1097/01.aog.0000113621.53602.7a
  22. Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91(10):4137-4143. doi: 10.1210/jc.2006-0980.
  23. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(2):112-119. doi: 10.2337/dc07-s202.
  24. D’Anna R, Baviera G, Cannata ML, De Vivo A, Di Benedetto A, Corrado F. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes. Gynecol Obstet Investigat. 2007;64(2):65-68. doi: 10.1159/000099149.
  25. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature Rev Immunol. 2011;11(2):85-97. doi: 10.1038/nri2921.
  26. Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes/Metabolism Research and Reviews. 2007;23(2):135-140. doi: 10.1002/dmrr.661.
  27. Zavalza-Gomez AB, Anaya-Prado R, Rincon-Sanchez AR, Mora-Martinez JM. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract. 2008;80(1):8-15. doi: 10.1016/j.diabres.2007.12.012.
  28. Altinova AE, Toruner F, Bozkurt N, Bukan N, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M. Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus. Gynecol Endocrinol. 2007;23(3):161-165. doi: 10.1080/09513590701227960.
  29. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol. 2007;66(3):447-453. doi: 10.1111/j.1365-2265.2007.02761.x
  30. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Pacora P, Yeo L, Gotsch F, Dong Z, Yoon BH, Hassan SS, Kusanovic JP. Maternal serum adiponectin multimers in gestational diabetes. J Perinatal Med. 2009;37(6):637-650. doi: 10.1515/jpm.2009.101.
  31. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Communications. 2002;290(3):1084-1089. doi: 10.1006/bbrc.2001.6307.
  32. Lain KY, Daftary AR, Ness RB, Roberts JM. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol. 2008;69(3):407-411. doi: 10.1111/j.1365-2265.2008.03198.x.
  33. Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, Hanley AJ. Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes. Diabetic Med. 2007;24(3):245-252. doi: 10.1111/j.1464-5491.2007.02077.x.
  34. Саприна Т.В., Тимохина Е.С., Мусина Н.Н., Прохоренко Т.С., Таширева Л.А., Гончаревич О.К. Панкреатические и экстрапанкреатические эффекты инкретинов и перспективы изучения энтероинсулярной гормональной системы у беременных женщин при гестационном нарушении углеводного обмена. Бюллетень сибирской медицины. 2013;3:132-147.
  35. Nadkarni P, Chepurny OG, Holz GG. Regulation of Glucose Homeostasis by GLP-1. Progress in Molecular Biology and Translational Science. 2014;121:23-65. doi: 10.1016/b978-0-12-800101-1.00002-8.
  36. Cypryk K, Vilsboll T, Nadel I, Smyczynska J, Holst JJ, Lewinski A. Normal secretion of the incretin hormones glucose-dependent insulinotropic poly-peptide and glucagon-like peptide-1 during gestational diabetes mellitus. Gynecol Endocrinol. 2007;23(1):58-62. doi: 10.1080/09513590601137004.
  37. Reyes-Lopez R, Perez-Luque E, Malacara JM. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women. Diabetes/Metabolism Research and Reviews. 2014;30(8):701-706. doi: 10.1002/dmrr.2538.
  38. Pacini G, Tura A, Winhofer Y, Kautzky-Willer A. Incretin Effect in Women with Former Gestational Diabeteswithin a Short Period after Delivery. Int J Endocrinol. 2012:1-4. doi: 10.1155/2012/247392.
  39. Arora C. Role of vitamin D in modulating gestational diabetes. Biopolymers and Cell. 2011;27(2):85-92. doi: 10.7124/bc.000087.
  40. Мальцева Л.И., Васильева Э.Н. Новые подходы к оценке роли витамина Д в репродуктивном здоровье женщины. Практическая медицина. 2013;7:42-47.
  41. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003;52(12):2951-2958. doi: 10.2337/diabetes.52.12.2951.
  42. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proceed. 2011;86(1):50-60. doi: 10.4065/mcp.2010.0567.
  43. Wolf M, Sauk J, Shah A, Smirnakis KV, Jimenez-Kimble R, Ecker JL, Thandhani R. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care. 2004;27(1):21-27. doi: 10.2337/diacare.27.1.21.
  44. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183(9):5458-5467. doi: 10.4049/jimmunol.0803217.
  45. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporosis International. 2005;16(7):713-716. doi: 10.1007/s00198-005-1867-7.
  46. Paolisso G, Scheen A, D’Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia. 1990;33:511-514. doi: 10.1007/bf00404136.
  47. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnesium Res. 2004;17:126-136.
  48. Yang SJ, Hwang SY, Baik SH, Lee KW, Nam MS, Park YS, Woo JT, Kim YS, Park S, Park So-Y, Yim CH, Yoon HK, Kim S-H. Serum Magnesium Level Is Associated with Type 2 Diabetes in Women with a History of Gestational Diabetes Mellitus: The Korea National Diabetes Program Study. J Korean Med Scie. 2014;29(1):84-89. doi: 10.3346/jkms.2014.29.1.84.
  49. Сучков С.В., Роуз Н., Ноткинс А., Голубничая О., Херрат М., Легг М., Маршалл Т. Введение в предиктивно-превентивную медицину: опыт прошлого и реальности дня завтрашнего. Терапевтический архив. 2012;8:81-85.

Statistics

Views

Abstract: 112

PDF (Russian): 53

Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2020 Prokhorenko T.S., Saprina T.V., Budeeva S.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies